Clinical Approach to Eating Disorders and Refeeding Syndrome Flashcards

1
Q

who is likely to develop an eating disorder?

A

women and adolescents

western societies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what ideology often accompanies eating disorders?

A

suicidality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

DSM5 criteria for anorexia nervosa (AN)

A

restriction of energy intake relative to requirements, leading to low body weight for age, sex and development

intense fear of gaining weight or becoming fat despite being underweight

distorted perception of body weight and shape or denial of low body weight

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

screening questions for eating DOs

A
  1. are you satisfied with your eating patterns?
  2. do you ever eat in secret?
  3. does your weight affect the way you feel about yourself?
  4. have any family members suffered with an eating disorder?
  5. do you currently suffer with or have suffered in the past with an eating DO?
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

restricting type AN

A

3 months of no binging or purging (no vomiting or lax)

excessive exercising, fasting, dieting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

binge-eating/purging type AN

A

3 months of binging and purging behaviors

self-induced vomiting
misuse of laxatives, diuretics, or enemas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

AN cardiac complications

A
bradycardia
hypotension
QT dispersion
cardiac atrophy
mitral valve prolapse
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

AN gynecologic complications

A

amenorrhea

decreased libido

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

AN endocrine complications

A

osteoporosis
hypothermia
euthyroid
hypoglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

AN GI complications

A

gastroparesis

constipation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

AN electrolyte complications

A

dehydration
hypokalemia
hypophosphatemia
hypomagnesia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

AN pulmonary complications

A

respiratory muscle atrophy

dyspnea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

AN hematologic complications

A

anemia
leukopenia
thrombocytopenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

AN neurologic complications

A

brain atrophy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

AN derm complications

A
xerosis (dry skin)
lanugo (peach fuzz)
carotenoderma (orange skin)
acrocyanosis (blue ext)
seborrheic dermatitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Refeeding syndrome

A

clinical complication that occurs as a result of fluid and electrolyte shifts during aggressive nutritional rehabilitation of malnourished patients

17
Q

complications of refeeding syndrome

A
hypophos
hypok
CHF
peripheral edema
rhabdomyolysis 
seizures
hemolysis
18
Q

how to avoid refeeding syndrome

A

limiting the amount of calories and fluid provided in early stages of refeeding

avoid rapid increases in the daily calories ingested

closely monitoring labs and the patient during the first few weeks of refeeding

19
Q

AN comorbidities

A

OCD
depression
impulse control DO
personality DO

20
Q

AN treatment

A

mental health clinician, registered dietitian and general medical clinician

nutritional rehab and psychotherapy

hospitalization to avoid refeeding syndrome, suicidality or starvation

hospitalization until normal weight achieved

meds may be used when depression/anxiety creating barriers to care

21
Q

AN nutritional rehab

A

supervised meals

2-3 lbs per week for inpatient

0.5-1 lb per week for outpatient

start at 30-40 Cals/kg and progressively increase

22
Q

AN psychotherapy

A

focus on helping patient confronting DO and change eating habits/thoughts of weight gain

cognitive behavioral therapy
specialist supportive clinical management
motivational interviewing
family therapy

23
Q

AN pharmacotherapy considerations

A

only for patients who have been resistant to other therapies

start at low doses

24
Q

AN meds

A

Olanzapine (anti-psych)
Lorazepam for anxiety
SSRI for anxiety or depression

25
Q

DSM5 criteria for bulimia nervosa (BN)

A

recurrent episodes of binge eating - eating large amounts of food in a discrete period of time

recurrent compensatory behavior to prevent weight gain (vomiting, lax)

binge/purge occurs at least 2x/week for 3 months

patients self-eval is influenced by body weight and shape

disturbance does not occur exclusively during an episode of AN

26
Q

BN considerations

A

patients vary between normal body weight, underweight or overweight

may use same weight loss tactics as AN

patients feel lack of control over binge eating but try to conceal it

dysphoria after binging

fearful of weight gain - may not want to become thin but just don’t want to become fat

27
Q

BN medical complications

A

similar to that of AN except:
Mallory-weiss syndrome/esophageal rupture

glandular hypertrophy

abd pain, bloating and constipation

tooth enamel erosion and caries

Russel’s sign - scar and callus on dorsum of hand

28
Q

BN comorbidities

A

anxiety
mood DO
substance abuse
personality DO

29
Q

BN treatment

A

combination of nutritional rehab, CBT psychotherapy and pharmacotherapy

30
Q

BN pharm considerations

A

less effective than CBT - best used in combo

avoid bupropion

31
Q

BN meds

A

fluoxetine

SSRIs

32
Q

DSM5 criteria for Binge Eating Disorder (BED)

A

episodes of binge eating

lack of control over eating

binge-eating marked by at least three of the following:
eating large amounts when not hungry
eating rapidly 
feels uncomfortably full after eating 
eating alone due to embarrassment
feeling of guilt after eating

episodes occur at least 1x/week for 3 months

33
Q

BED treatment

A

CBT and interpersonal therapy are most effective

pharmacotherapy used in combo with psychotherapy

34
Q

BED pharmacotherapy

A

Vyvanse
SSRIs

*anti-obesity drugs NOT recommended